Published on February 13th, 2013
ScreenCell sponsors TriCON 2013 from Feb 13-15 in San Francisco
Sarah P. Thayer, M.D., Ph.D. / Associate Professor of Surgery; W. Gerald Austen Scholar in Academic Surgery; Director, Pancreatic Biology Laboratory / Massachusetts General Hospital
The capture, growth and genetic analysis of CTC in PDAC: What can it tell us about this disease?
CTC captured by ScreenCell devices were detected in patients with resectable PDAC. These CTC are capable of in-vitro growth confirming tumorigenicity. Selective deep sequencing demonstrated the feasibility of identifying mutations present in the primary tumor and their corresponding CTC.